Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
|
Common Stock [Member] |
Additional Paid-in Capital [Member] |
Treasury Stock [Member] |
Noncontrolling Interest [Member] |
Retained Earnings [Member] |
Total |
Beginning balance, value at Dec. 31, 2020 |
$ 26,835
|
$ 106,501,396
|
$ (2,157,226)
|
|
$ (90,014,500)
|
$ 14,356,505
|
Beginning balance, shares at Dec. 31, 2020 |
26,834,709
|
|
|
|
|
|
Stock-based compensation |
|
326,164
|
|
|
|
326,164
|
Restricted common stock grant |
$ 450
|
(450)
|
|
|
|
|
Restricted common stock grant, shares |
450,000
|
|
|
|
|
|
Restricted common stock forfeitures |
$ (8)
|
8
|
|
|
|
|
Restricted common stock forfeitures, shares |
(7,500)
|
|
|
|
|
|
Issuance of common stock through registered direct offering at $3.095 per share and accompanying warrants (net of offering expenses and placement agent discount) |
$ 2,800
|
6,726,200
|
|
|
|
6,729,000
|
Issuance of common stock through registered direct offering at $3.095 per share and accompanying warrants (net of offering expenses and placement agent discount), shares |
2,800,000
|
|
|
|
|
|
Issuance of common stock through registered direct offering at $2.80 per share and accompanying warrants (net of offering expenses and placement agent discount) |
$ 3,250
|
6,614,350
|
|
|
|
6,617,600
|
Issuance of common stock through registered direct offering at $2.80 per share and accompanying warrants (net of offering expenses and placement agent discount), shares |
3,250,000
|
|
|
|
|
|
Exercise of pre-funded common stock purchase warrants at $3.095 per share |
$ 7,200
|
22,276,800
|
|
|
|
22,284,000
|
Exercise of pre-funded common stock purchase warrants at $3.095 per share, shares |
7,200,000
|
|
|
|
|
|
Exercise of pre-funded common stock purchase warrants at $2.80 per share |
$ 11,050
|
30,928,950
|
|
|
|
30,940,000
|
Exercise of pre-funded common stock purchase warrants at $2.80 per share, shares |
11,050,000
|
|
|
|
|
|
Issuance of pre-funded common stock purchase warrants in connection with the registered direct offerings |
|
(1,817,548)
|
|
|
|
(1,817,548)
|
Issuance of common stock purchase warrants at exercise price of $3.25 per share in connection with the registered direct offerings |
|
(49,398,510)
|
|
|
|
(49,398,510)
|
Net income (loss) |
|
|
|
|
21,721,858
|
21,721,858
|
Ending balance, value at Mar. 31, 2021 |
$ 51,577
|
122,157,360
|
(2,157,226)
|
|
(68,292,642)
|
51,759,069
|
Ending balance, shares at Mar. 31, 2021 |
51,577,209
|
|
|
|
|
|
Beginning balance, value at Dec. 31, 2020 |
$ 26,835
|
106,501,396
|
(2,157,226)
|
|
(90,014,500)
|
14,356,505
|
Beginning balance, shares at Dec. 31, 2020 |
26,834,709
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
24,388,307
|
Ending balance, value at Sep. 30, 2021 |
$ 52,703
|
123,968,757
|
(2,157,226)
|
(19,863)
|
(65,606,330)
|
56,238,041
|
Ending balance, shares at Sep. 30, 2021 |
52,702,947
|
|
|
|
|
|
Beginning balance, value at Mar. 31, 2021 |
$ 51,577
|
122,157,360
|
(2,157,226)
|
|
(68,292,642)
|
51,759,069
|
Beginning balance, shares at Mar. 31, 2021 |
51,577,209
|
|
|
|
|
|
Stock-based compensation |
|
330,213
|
|
|
|
330,213
|
Net income (loss) |
|
|
|
|
(5,382,487)
|
(5,382,487)
|
Ending balance, value at Jun. 30, 2021 |
$ 51,577
|
122,487,573
|
(2,157,226)
|
|
(73,675,129)
|
46,706,795
|
Ending balance, shares at Jun. 30, 2021 |
51,577,209
|
|
|
|
|
|
Stock-based compensation |
|
491,950
|
|
|
|
491,950
|
Restricted common stock grant |
$ 406
|
(406)
|
|
|
|
|
Restricted common stock grant, shares |
406,000
|
|
|
|
|
|
Net income (loss) |
|
|
|
(19,863)
|
8,068,799
|
8,048,936
|
Issuance of common stock as consideration for acquisition |
$ 720
|
989,640
|
|
|
|
990,360
|
Issuance of common stock as consideration for acquisition, shares |
719,738
|
|
|
|
|
|
Ending balance, value at Sep. 30, 2021 |
$ 52,703
|
123,968,757
|
(2,157,226)
|
(19,863)
|
(65,606,330)
|
56,238,041
|
Ending balance, shares at Sep. 30, 2021 |
52,702,947
|
|
|
|
|
|
Beginning balance, value at Dec. 31, 2021 |
$ 50,904
|
124,426,379
|
|
56,453
|
(68,670,497)
|
55,863,239
|
Beginning balance, shares at Dec. 31, 2021 |
50,904,391
|
|
|
|
|
|
Stock-based compensation |
|
394,749
|
|
|
|
394,749
|
Restricted common stock grant |
$ 715
|
(715)
|
|
|
|
|
Restricted common stock grant, shares |
715,000
|
|
|
|
|
|
Restricted common stock forfeitures |
$ (15)
|
15
|
|
|
|
|
Restricted common stock forfeitures, shares |
(15,000)
|
|
|
|
|
|
Net income (loss) |
|
|
|
(98,094)
|
(6,600,148)
|
(6,698,242)
|
Repurchase and cancellation of common stock |
$ (1,876)
|
|
|
|
(2,061,892)
|
(2,063,768)
|
Repurchase and cancellation of common stock, shares |
(1,876,034)
|
|
|
|
|
|
Distribution to noncontrolling interest in consolidated subsidiary |
|
|
|
(15,692)
|
|
(15,692)
|
Ending balance, value at Mar. 31, 2022 |
$ 49,728
|
124,820,428
|
|
(57,333)
|
(77,332,537)
|
47,480,286
|
Ending balance, shares at Mar. 31, 2022 |
49,728,357
|
|
|
|
|
|
Beginning balance, value at Dec. 31, 2021 |
$ 50,904
|
124,426,379
|
|
56,453
|
(68,670,497)
|
55,863,239
|
Beginning balance, shares at Dec. 31, 2021 |
50,904,391
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
(9,299,498)
|
Ending balance, value at Sep. 30, 2022 |
$ 53,903
|
129,943,238
|
|
309,397
|
(82,261,430)
|
48,045,108
|
Ending balance, shares at Sep. 30, 2022 |
53,903,405
|
|
|
|
|
|
Beginning balance, value at Mar. 31, 2022 |
$ 49,728
|
124,820,428
|
|
(57,333)
|
(77,332,537)
|
47,480,286
|
Beginning balance, shares at Mar. 31, 2022 |
49,728,357
|
|
|
|
|
|
Stock-based compensation |
|
381,602
|
|
|
|
381,602
|
Restricted common stock forfeitures |
$ (50)
|
50
|
|
|
|
|
Restricted common stock forfeitures, shares |
(50,000)
|
|
|
|
|
|
Net income (loss) |
|
|
|
383,326
|
(1,065,513)
|
(682,187)
|
Repurchase and cancellation of common stock |
$ (1,850)
|
|
|
|
(1,960,905)
|
(1,962,755)
|
Repurchase and cancellation of common stock, shares |
(1,849,952)
|
|
|
|
|
|
Ending balance, value at Jun. 30, 2022 |
$ 47,828
|
125,202,080
|
|
325,993
|
(80,358,955)
|
45,216,946
|
Ending balance, shares at Jun. 30, 2022 |
47,828,405
|
|
|
|
|
|
Stock-based compensation |
|
251,733
|
|
|
|
251,733
|
Net income (loss) |
|
|
|
(16,596)
|
(1,902,475)
|
(1,919,071)
|
Issuance of common stock through warrant exchange agreement |
$ 6,075
|
4,489,425
|
|
|
|
4,495,500
|
Issuance of common stock through warrant exchange agreement, shares |
6,075,000
|
|
|
|
|
|
Ending balance, value at Sep. 30, 2022 |
$ 53,903
|
$ 129,943,238
|
|
$ 309,397
|
$ (82,261,430)
|
$ 48,045,108
|
Ending balance, shares at Sep. 30, 2022 |
53,903,405
|
|
|
|
|
|